Eradication of a Large Outbreak of a Single Strain of vanB Vancomycin-Resistant Enterococcus faecium at a Major Australian Teaching Hospital

Infection Control and Hospital Epidemiology

Volumn 25, Issue 5, 2004, Pages 384-390

  Christiansen, Keryn J ^a,b   Tibbett, Patricia A ^a   Beresford, William ^c   Pearman, John W ^a   Lee, Rosie C ^a   Coombs, Geoffrey W ^a   Kay, Ian D ^a   O'Brien, Frances G ^b   Palladino, Silvano ^a   Douglas, Charles R ^a   Montgomery, Philip D ^a   Orrell, Terri ^a   Peterson, Allison M ^a   Kosaras, Frank P ^a   Flexman, James P ^a   Heath, Christopher H ^a   McCullough, Cheryll A ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c Women's and Children's Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; ENDEMIC DISEASE; ENTEROCOCCUS FAECIUM; EPIDEMIC; ERADICATION THERAPY; GENE VANB; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MASS SCREENING; NONHUMAN; POLYMERASE CHAIN REACTION;

COHORT STUDIES; ENTEROCOCCUS FAECIUM; HOSPITALS, TEACHING; HUMANS; VANCOMYCIN RESISTANCE; WESTERN AUSTRALIA;

EID: 2442483761     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502410     Document Type: Article

References (38)

1. National Nosocomial Infections Surveillance (NNIS) System. National Nosocomial Infections Surveillance System report: data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001;29:404-421.
2. Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Exterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996;23:767-772.
3. Stroud L, Edwards J, Danzing L, Culver D, Gaynes R. Risk factors for mortality associated with enterococcal bloodstream infections. Infect Control Hosp Epidemiol 1996;17:576-580.
4. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993-1000.
5. Garbutt JM, Ventrapragada M, Littenberg B, Mundy LM. Association between resistance to vancomycin and death in cases of Exterococcus faecium bacteremia. Clin Infect Dis 2000;30:466-472.
6. Bhavnani SM, Drake JA, Forrest A, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000;36:145-158.
7. Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clin Infect Dis 2002;34:922-929.
8. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 2002;162:2223-2228.
9. Recommendations for preventing the spread of vancomycin resistance. MMWR 1995;44(RR-12):1-13.
10. Lai KK, Kelley AL, Melvin ZS, Belliveau PP, Fontecchio SA. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Infect Control Hosp Epidemiol 1998;19:647-652.
11. Quale J, Landman D, Atwood E, et al. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control 1996;24:372-379.
12. Byers KE, Anglim AM, Annesld CJ, et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001;22:140-147.
13. Muto CA, Giannetta ET, Durbin IJ, Simonton BM, Farr BM. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002;23:429-435.
14. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Exterococcus faecium with transferable VanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-1153.
15. Timmers GJ, van der Zwet WC, Simoons-Smit IM, et al. Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br J Haematol 2002;116:826-833.
16. Hanna H, Umphrey J, Tarrand J, Mendoza M, Raad I. Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center. Infect Control Hosp Epidemiol 2001;22:217-219.
17. Falk PS, Winnike J, Woodmansee C, Desai M, Mayhall CG. Outbreak of vancomycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol 2000;21:575-582.
18. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001;344:1427-1433.
19. Turnidge JD, Nimmo GR, Francis G. Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals. Med J Aust 1996;164:68-71.
20. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020-1025.
21. Palladino S, Kay ID, Costa AM, Lambert EJ, Flexman JP. Real-time PCR for the rapid detection of vanA and vanB genes. Diagn Microbiol Infect Dis 2002;45:81-84.
22. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002. M100-12.
23. Kulski JK, Wilson RD, Bending R, Grubb WB. Antibiotic resistance and genomic analysis of enterococci in an intensive care unit and general wards. Pathology 1998;30:68-72.
24. Townsend DE, Ashdown N, Bolton S, Grubb WB. The use of cetyltrimethylammonium bromide for the isolation from Staphylococcus aureus of relaxable and non-relaxable DNA for in-vitro manipulation. Lett Appl Microbiol 1985;1:207-212.
25. Bruce J. Automated system rapidly identifies and characterizes microorganisms in food. Food Technology 1996;50:77-81.
26. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:22332239.
27. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Index With Defined Daily Doses (DDDs). Oslo, Norway: World Health Organization Collaborating Centre for Drug Statistics Methodology; 2002.
28. Weber DJ, Rutala WA. Role of environmental contamination in the transmission of vancomycin resistant enterococci. Infect Control Hosp Epidemiol 1997;18:306-309.
29. Zachary KC, Bayne PS, Morrison VJ, Ford DS, Silver LC, Hooper DC. Contamination of gowns, gloves, and stethoscopes with van-comycin-resistant enterococci. Infect Control Hosp Epidemiol 2001;22:560-564.
30. Opal SM, Mayer KH, Stenberg MJ, et al. Frequent acquisition of multiple strains of methicillin-resistant Staphylococcus aureus by health-care workers in an endemic hospital environment. Infect Control Hosp Epidemiol 1990;11:479-485.
31. Cookson B, Peters B, Webster M, Phillips I, Rahman M, Noble W. Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1989;27:1471-1476.
32. D'Agata EM, Gautam S, Green WK, Tang YW. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 2002;34:167-172.
33. Bradley SJ, Wilson AL, Allen MC, Sher HA, Goldstone AH, Scott GM. The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. J Antimicrob Chemother 1999;43:261-266.
34. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23:1234-1239.
35. Stosor V, Peterson LR, Postelnick M, Noskin GA. Exterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998;158:522-527.
36. Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Exterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992;72:195-198.
37. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin: United States, 2002. MMWR 2002;51:565-567.
38. Centers for Disease Control and Prevention. Public Health Dispatch: vancomycin-resistant Staphylococcus aureus-Pennsylvania, 2002. MMWR 2002;51:902.